Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00787384Phase 2Completed
Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Chronic Eosinophilic LeukemiaChronic Idiopathic HypereosinophiliaHypereosinophilic Syndrome
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00787384Phase 2PrincipalInvestigator

Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Chronic Eosinophilic LeukemiaChronic Idiopathic HypereosinophiliaHypereosinophilic Syndrome
Completed
NCT01290120Phase 2PrincipalInvestigator

Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma

B-ALLBurkitt Lymphoma
Completed

All 2 trials loaded